358 related articles for article (PubMed ID: 10443691)
1. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
[TBL] [Abstract][Full Text] [Related]
2. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
Chan DC; Watts GF; Barrett PH; Mori TA; Beilin LJ; Redgrave TG
J Clin Endocrinol Metab; 2002 May; 87(5):2283-9. PubMed ID: 11994377
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
[TBL] [Abstract][Full Text] [Related]
5. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
[TBL] [Abstract][Full Text] [Related]
6. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Watts GF; Chan DC; Barrett PH
Metabolism; 2002 Sep; 51(9):1206-10. PubMed ID: 12200768
[TBL] [Abstract][Full Text] [Related]
8. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
9. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
10. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
[TBL] [Abstract][Full Text] [Related]
11. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
12. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.
Watts GF; Riches FM; Humphries SE; Talmud PJ; van Bockxmeer FM
J Lipid Res; 2000 Mar; 41(3):481-8. PubMed ID: 10706596
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men.
Watts GF; Riches FM; Kelly JM; Powell MA; Croft KD
Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):556-62. PubMed ID: 9269527
[TBL] [Abstract][Full Text] [Related]
17. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
18. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
